Log in

Relevant bibliographies by topics / Anti diabetic drugs / Journal articles

To see the other types of publications on this topic, follow the link: Anti diabetic drugs.

Journal articles on the topic 'Anti diabetic drugs'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Anti diabetic drugs.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Ulfa, Ridha, Syarifah NYRS Assegaf, and Mistika Zakia. "PEDULI PENYAKIT TIDAK MENULAR DENGAN SKRINING KESEHATAN, BEDAH BUKU DAN PENYULUHAN PENGGUNAAN OBAT ANTI DIABETIK, OBAT HIPERURISEMIA DAN OBAT DISLIPIDEMIA YANG RASIONAL." Medical Dedication (medic) : Jurnal Pengabdian kepada Masyarakat FKIK UNJA 5, no. 1 (2022): 396–402. http://dx.doi.org/10.22437/medicaldedication.v5i1.18681.

Full text

Abstract:

Abstract Concerned for non-communicable diseases by health screening, book review and counseling on the rational use of anti-diabetic drugs, hyperuricemia drugs and dyslipidemia drugs. The purpose of this community service is to increase public knowledge about the dangers of Non-Communicable Diseases (NCD), including cardiovascular disease, diabetes mellitus, dyslipidemia, and hyperuricemia. As well as increasing public awareness about the rational use of anti-diabetic drugs, hyperuricemia drugs and dyslipidemia drugs. The methods of this activity are health checks, blood tests, counseli

APA, Harvard, Vancouver, ISO, and other styles

2

Nanda, Oryza Dwi, Bambang Wiryanto, and Erwin Astha Triyono. "Hubungan Kepatuhan Minum Obat Anti Diabetik dengan Regulasi Kadar Gula Darah pada Pasien Perempuan Diabetes Mellitus." Amerta Nutrition 2, no. 4 (2018): 340. http://dx.doi.org/10.20473/amnt.v2i4.2018.340-348.

Full text

Abstract:

Background: Blood glucose level controlling is the important thing for diabetes mellitus treatment. Diabetics patients need to understand the factors which influence blood glucose level such as the compliance of anti-diabetic drug.Objective: Determine the relationship and the risk of between oral anti-diabetic drug consumption adherence and blood glucose level regulation for diabetes mellitus female patients.Method: Case control study design with purposive sampling technique, in order to obtain 26 research samples which consist of two groups, they are case group (unregulated blood glucose) whi

APA, Harvard, Vancouver, ISO, and other styles

3

Walia, Smily, J. S. Dua, and D. N. Prasad. "Herbal Drugs with Anti-Diabetic Potential." Journal of Drug Delivery and Therapeutics 11, no. 6 (2021): 248–56. http://dx.doi.org/10.22270/jddt.v11i6.5051.

Full text

Abstract:

Diabetes mellitus (DM), also known as insulin-dependent diabetes mellitus (IDDM) and non-insulin dependent diabetes mellitus (NIDDM), is a common and serious metabolic condition that affects people all over the world. Traditional herbal plants have been utilized to treat diabetes mellitus all throughout the world. Several herbs have been found to treat and control diabetes among numerous medicines and poly herbal plants; they also have no adverse effects. Diabetes mellitus is a horrible disease that affects people all over the world and is becoming a serious danger to humanity's health. Thus,

APA, Harvard, Vancouver, ISO, and other styles

4

Sasikumar, Amithkumar, and Sheetal S. "Bruns–Garland syndrome precipitated by anti-tuberculous therapy in a patient with type 2 diabetes mellitus." Nepal Journal of Neuroscience 19, no. 1 (2022): 66–67. http://dx.doi.org/10.3126/njn.v19i1.40952.

Full text

Abstract:

India has a high prevalence of tuberculosis as well as diabetes mellitus, and both contribute to a major disease burden. Diabetes mellitus increases the risk of tuberculosis. Patients with diabetes are more prone to develop cavitary lesions than non-diabetics. Tuberculosis can worsen the glycemic status of an individual and anti-tuberculous drugs like Rifampicin can interact with oral anti-diabetic drugs, further worsening the glycemic control. This can result in complications related to diabetes, like diabetic amyotrophy. We hereby report the case of a 69-year-old gentleman with diabetes mell

APA, Harvard, Vancouver, ISO, and other styles

5

Shaha, Kartick Chanda, Sharmin Jahan, Md Ziaur Rahman Mamun, Md Shafiqur Rahman, Farjana Ahmed, and Bhagyashree Karmokar Jyoti. "Prescribing patterns of anti-diabetic drugs among type 2 diabetic patients at a private Medical College Hospital in Mymensingh." Journal of Dhaka National Medical College & Hospital 23, no. 1 (2017): 29–32. https://doi.org/10.3329/jdnmch.v23i1.78063.

Full text

Abstract:

Background: The right choice of anti-diabetic drugs among type 2 diabetic patients carries a vital role. Objective: The aim of the present study was to evaluate the prescribing patterns of anti-diabetic drugs among type 2 diabetic patients at tertiary level teaching hospital in Mymensingh. Methods: A descriptive, cross sectional study was conducted from July 2015 to June 2016 among patients attending at Medicine Outpatient Department of the Community Based Medical College Hospital. Data were collected through the reviewing of the prescriptions and interviewing of the patients. The collected da

APA, Harvard, Vancouver, ISO, and other styles

6

Siddhi, Nigade* Dinesh Ingole Arundhati Kore Jagruti Shelar. "Review On Anti-Diabetic Drug and Treatment." International Journal of Pharmaceutical Sciences 3, no. 6 (2025): 185–95. https://doi.org/10.5281/zenodo.15574490.

Full text

Abstract:

Diabetes is the third leading cause of death in the United States, and is one of the world's major diseases. Diabetes is a metabolic disorder which is mainly characterized by hyperglycemia and arises from defects in insulin action or both. Approximately 2% of the population in India suffer from diabetes. Anti-diabetic drugs lower the levels of sugar in the blood. Most anti-diabetic drugs are administered by mouth. There are different types of anti-diabetic drugs and their selection depends on a number of factors. Treatments include the agents which increase the amount of insulin produced by th

APA, Harvard, Vancouver, ISO, and other styles

7

Singh, Ved Prakash. "An Overview on Anti Diabetic Drugs and Development." Science & Technology Journal 4, no. 2 (2016): 113–23. http://dx.doi.org/10.22232/stj.2016.04.02.05.

Full text

Abstract:

Diabetes mellitus is one of the world’s major diseases and is the third leading cause of death in the United States after heart disease and cancer. In the India, about 2–6% population suffer from diabetes or related complication. Anti-diabetic drugs treat diabetes mellitus by lowering glucose levels in the blood. Mostly anti-diabetic drugs are administered orally except the insulin, exenatide, and pramlintide. There are different types of anti-diabetic drugs, and their selection depends on the nature of the diabetes, age and situation of the person, and many other factors. Treatments include t

APA, Harvard, Vancouver, ISO, and other styles

8

Devkota, HP, A. Adhikari-Devkota, S. Yahara, and P. Basnet. "Anti-oxidative Activity of Nepalese Traditional Anti-diabetic Medicines." Nepal Journal of Science and Technology 14, no. 2 (2014): 151–54. http://dx.doi.org/10.3126/njst.v14i2.10429.

Full text

Abstract:

Chronic overproduction of free radicals in human body has a role in numerous disease states including diabetes. Proper use of antioxidants may help in the prevention and/or treatment of diabetes. For the management of diabetes, a combination of herbal drugs is being practiced traditionally in Nepal. These herbal medicines might have a good correlation to anti-oxidative properties. Anti-oxidative property was evaluated with the methanolic extracts of nineteen common traditional anti-diabetic medicines by 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging method. Among the evaluated herbal

APA, Harvard, Vancouver, ISO, and other styles

9

Kapur, Ajita, Harmeet Singh Rehan, Lalit Kumar Gupta, and Madhur Yadav. "Pattern of anti-diabetic drugs prescribed for type 2 diabetes mellitus patients in a tertiary care hospital of India: an observational study." International Journal of Basic & Clinical Pharmacology 8, no. 7 (2019): 1657. http://dx.doi.org/10.18203/2319-2003.ijbcp20192667.

Full text

Abstract:

Background: Type 2 diabetes mellitus (T2DM) is a leading cause of significant morbidity and mortality in developing countries. Evaluation of anti-diabetic drug use pattern guides the healthcare professionals to identify early signals of irrational prescribing and to plan interventions to optimize the benefits of pharmacotherapy.Methods: Observational descriptive study was conducted on 500 prescriptions of T2DM patients collected from Outpatient department of a tertiary care hospital. Prescriptions were analysed for type, number, generic/brand names, fixed dose combinations (FDCs) of anti-diabe

APA, Harvard, Vancouver, ISO, and other styles

10

Galstyan, Gagik R., Ekaterina A. Shestakova, and Igor A. Sklyanik. "Obesity and type 2 diabetes: can we find a compromised treatment solution?" Diabetes mellitus 20, no. 4 (2017): 270–78. http://dx.doi.org/10.14341/dm8726.

Full text

Abstract:

Type 2 diabetes and obesity are two enormous epidemic diseases of the 21stcentury. Because obesity is a primary risk factor for type 2 diabetes development, patients with diabetes are frequently obese. This comorbidity makes it challenging for these patients to not only compensate diabetes but also bring their weight back to normal. Several anti-diabetic drugs cause weight gain, which augments insulin resistance, and thus demands anti-diabetic treatment intensification. For the treatment, it is crucial to find an anti-diabetic treatment drug that is efficient but does not cause weight gain. In

APA, Harvard, Vancouver, ISO, and other styles

11

Chekhonin, E. S., and O. A. Pavlovskiy. "ANTI-VEGF THERAPY FOR DIABETIC RETINOPATHY." Bulletin of Pirogov National Medical & Surgical Center 19, no. 4 (2024): 119–23. http://dx.doi.org/10.25881/20728255_2024_19_4_s1_119.

Full text

Abstract:

Diabetic retinopathy is one of the most severe complications of diabetes mellitus, requiring the participation of doctors of various specialties: endocrinologists, diabetologists, therapists, cardiologists, surgeons, anesthesiologists and others.The task of an ophthalmologist is to identify pathological changes in the eye associated with diabetes mellitus and prescribe appropriate treatment.There are three main methods for treating diabetic retinopathy: laser coagulation of the retina;intravitreal injections of anti-VEGF and glucocorticoids;vitreoretinal surgery.This literature review examines

APA, Harvard, Vancouver, ISO, and other styles

12

Agyemang, Kojo, Lifeng Han, Erwei Liu, Yi Zhang, Tao Wang, and Xiumei Gao. "Recent Advances inAstragalus membranaceusAnti-Diabetic Research: Pharmacological Effects of Its Phytochemical Constituents." Evidence-Based Complementary and Alternative Medicine 2013 (2013): 1–9. http://dx.doi.org/10.1155/2013/654643.

Full text

Abstract:

The disease burden of diabetes mellitus is increasing throughout the world. The need for more potent drugs to complement the present anti-diabetic drugs has become an imperative.Astragalus membranaceus, a key component of most Chinese herbal anti-diabetic formulas, has been an important prospect for lead anti-diabetic compounds. It has been progressively studied for its anti-diabetic properties. Ethnopharmacological studies have established its potential to alleviate diabetes mellitus. Recent studies have sought to relate its chemical constituents to types 1 and 2 diabetes mellitus. Its total

APA, Harvard, Vancouver, ISO, and other styles

13

CHEN, SHYI-MING, YUN-HOU HUANG, and RUNG-CHING CHEN. "A RECOMMENDATION SYSTEM FOR ANTI-DIABETIC DRUGS SELECTION BASED ON FUZZY REASONING AND ONTOLOGY TECHNIQUES." International Journal of Pattern Recognition and Artificial Intelligence 27, no. 04 (2013): 1359001. http://dx.doi.org/10.1142/s0218001413590015.

Full text

Abstract:

Diabetes mellitus is a common chronic disease in recent years. According to the World Health Organization, the estimated number of diabetic patients will increase 56% in Asia from the year 2010 to 2025, where the number of anti-diabetic drugs that doctors are able to utilize also increase as the development of pharmaceutical drugs. In this paper, we present a recommendation system for anti-diabetic drugs selection based on fuzzy reasoning and ontology techniques, where fuzzy rules are used to represent knowledge to infer the usability of the classes of anti-diabetic drugs based on fuzzy reason

APA, Harvard, Vancouver, ISO, and other styles

14

Andi Hutami Endang. "Expert System of Anti-Diabetic Medicine Selection." Journal of Computer Science and Informatics Engineering (J-Cosine) 5, no. 2 (2021): 175–82. http://dx.doi.org/10.29303/jcosine.v5i2.425.

Full text

Abstract:

The Prediction of World Health Organization (WHO) estimates that in 2030 the number of diabetics in Indonesia reached approximately 21.3 million people. Moreover, the development of medicine consumed by diabetics also varies. In this paper, we present a system that represents a diabetes expert into a knowledge based on the domain ontology. The early stage of the system is developing drugs ontology (including functions and contraindications) and patient ontology. Then, matching a weighted ontology will give drugs recommendations that are suitable with the patient's condition. The system is able

APA, Harvard, Vancouver, ISO, and other styles

15

Mehani, Rekha, and Parag Sharma. "Cost variation analysis of oral anti-diabetic drugs." International Journal of Basic & Clinical Pharmacology 7, no. 9 (2018): 1709. http://dx.doi.org/10.18203/2319-2003.ijbcp20183476.

Full text

Abstract:

Background: Diabetes Mellitus is a chronic metabolic disorder, one of the major causes of morbidity, mortality and needs lifelong treatment. There are large numbers of oral anti-diabetic drugs available for the treatment of type 2 diabetes mellitus. There are numerous brands available for each of the individual oral anti-diabetic drug. Thus, a study was planned to find out cost variation among different brands of same active oral anti-diabetic drug.Methods: Cost of a particular drug being manufactured by different companies, in the same strength and dosage forms was obtained from the price lis

APA, Harvard, Vancouver, ISO, and other styles

16

Hadid, Khalil A., Fawaz A. Alassaf, and Mohammed N. Abed. "Beyond blood sugar: exploring the anti-inflammatory frontier of antidiabetic medications to alleviate diabetic complications." Romanian Journal of Medical Practice 19, no. 1 (2024): 76–83. http://dx.doi.org/10.37897/rjmp.2024.1.11.

Full text

Abstract:

Background and objective. Inflammation is closely correlated with diabetes and diabetic complications. Research has shown that individuals with diabetes exhibit an upregulation of circulatory proinflammatory cytokines, resulting in a chronic state of low-grade inflammation. The participation of inflammation in the pathogenesis of diabetic complications, particularly cardiovascular and renal complications, is well-established. Targeting inflammation may produce prominent effects in improving the clinical condition of diabetic patients, reducing the progression of complications, and promoting gl

APA, Harvard, Vancouver, ISO, and other styles

17

P., Anil Kumar, and Raj Kumar K. "Prescribing pattern of antidiabetic drugs in tertiary care hospital." International Journal of Basic & Clinical Pharmacology 10, no. 3 (2021): 251. http://dx.doi.org/10.18203/2319-2003.ijbcp20210555.

Full text

Abstract:

Background: The aim of the current study was to investigate the prescribing pattern of anti-diabetic drugs in diabetic patients attending tertiary care teaching hospital in Kurnool.Methods: A prospective, cross-sectional, observational survey was carried out in 100 patients of diabetes mellitus attending diabetes outpatient/medicine outpatient departments, to assess their prescribing pattern of anti-diabetic drugs.Results: Average number of anti-diabetic drugs per prescription was 1.4. Metformin (biguanide) was the commonest prescribed individual drug among oral hypoglycemic agents. Fixed dose

APA, Harvard, Vancouver, ISO, and other styles

18

Kim, Se-Eun, and Byung-Su Yoo. "Anti-Diabetic Drugs in Cardiovascular Disease." Korean Journal of Medicine 96, no. 2 (2021): 85–91. http://dx.doi.org/10.3904/kjm.2021.96.2.85.

Full text

Abstract:

Diabetes is one of the important risk factors in cardiovascular disease associated with atherosclerosis, and cardiovascular disease is the leading cause of death in patients with diabetes mellitus. Recent randomized placebo-controlled cardiovascular outcome trials of all new antidiabetic drugs have linked SGLT-2 inhibitors and GLP1-agonists to not only increased cardiovascular stability but significant reduction of cardiovascular disease. These results have led to preferential selection of the most effective and beneficial antidiabetic drugs with the evidence of cardiovascular safety and effic

APA, Harvard, Vancouver, ISO, and other styles

19

Swetha E. Jeganathan, V. "Anti-Angiogenesis Drugs in Diabetic Retinopathy." Current Pharmaceutical Biotechnology 12, no. 3 (2011): 369–72. http://dx.doi.org/10.2174/138920111794480525.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Kumar, R., D. M. Kerins, and T. Walther. "Cardiovascular safety of anti-diabetic drugs." European Heart Journal - Cardiovascular Pharmacotherapy 2, no. 1 (2015): 32–43. http://dx.doi.org/10.1093/ehjcvp/pvv035.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Abouzekry, Sara S., Marwa T. Badawy, Nada M. Ezzelarab, and Ahmed Abdellatif. "Phytotherapy for diabetes mellitus; A review of Middle Eastern and North African folk medicinal plants." Journal of Herbmed Pharmacology 10, no. 1 (2020): 1–13. http://dx.doi.org/10.34172/jhp.2021.01.

Full text

Abstract:

Diabetes mellitus (DM) is considered as one of the most common metabolic disorders affecting huge number of people worldwide. Despite the availability of large numbers of drugs in the market to treat the disease, there is still a need for new sources to deal with the problem and avoid side effects. In the pursuit of discovering safer and more effective anti-diabetic drugs, herbal and folk medicine drugs from regions all over the world have captured researchers’ interest. Middle Eastern and North African medicinal plants contain a variety of pharmacologically active components that have shown t

APA, Harvard, Vancouver, ISO, and other styles

22

Kaur, Pardeep, Munish Kumar, Jyoti Parkash, and D. N. Prasad. "Oral hypoglycemic drugs: An overview." Journal of Drug Delivery and Therapeutics 9, no. 3-s (2019): 770–77. http://dx.doi.org/10.22270/jddt.v9i3-s.2815.

Full text

Abstract:

The aim of this study was to evaluate safety and efficacy of oral hypoglycemic agents in obese Type-2 diabetic patients. The objectives are to compare fasting and postprandial blood sugar (PPBS) levels, to compare body mass index in all the groups and to identify glycosylated hemoglobin levels and adverse drug reaction in all the groups. Diabetes mellitus is one of the world’s major diseases. It currently affects an estimated143 million people worldwide and the number is growing rapidly. In the India, about 1-5% population suffer from diabetes or related complication. So there is need to cure

APA, Harvard, Vancouver, ISO, and other styles

23

Dalvi, K. V., and Meenal D. Lad. "EXPERIMENTAL STUDY OF ATIBALA (ABUTILON INDICUM LINN SWEET) ROOT WITH EQUAL QUANTITY OF SUGAR (SITA) AND COW MILK (GODUGDDHA) IN RELATION TO ANTI-DIABETIC ACTIVITY IN STREPTOZOTOCIN INDUCED ALBINO WISTAR RATS." International Journal of Advanced Research 11, no. 11 (2023): 150–57. http://dx.doi.org/10.21474/ijar01/17812.

Full text

Abstract:

Background: Diabetes mellitus, a clinical syndrome developed due to absolute or relative deficiency of insulin and it is mainly characterized by hyperglycemia. It has high prevalence and it is fast gaining status of potential epidemic. Thats why many synthetic drugs are available to treat the diabetes which is costly and giving serious side effects after long use. The herbs are safe and cost effective to treat diabetes. Ayurved classic (Bhavapraksh Nighantu) mentioned Atibala root with Sita (sugar) and Godugddha (Cow milk) have anti-diabetetic activity. As the Diabetes mellitus is most conside

APA, Harvard, Vancouver, ISO, and other styles

24

Shyam, Sharvari, and Bhavya Darshini Mahanthegowda. "A cost variation analysis of various brands of oral anti-diabetic drugs currently available in Indian pharmaceutical market." International Journal of Basic & Clinical Pharmacology 9, no. 8 (2020): 1253. http://dx.doi.org/10.18203/2319-2003.ijbcp20203144.

Full text

Abstract:

Background: Diabetes mellitus is a metabolic disorder requiring lifelong treatment. There are a large number of anti-diabetic drugs available in the Indian market. The cost of drugs plays an important role in patient’s care, warranting the need for all physicians to keep themselves updated with the latest prices and price variation of various brands of anti-diabetic drugs. The objective of this study is to evaluate the cost of oral anti-diabetic drugs of different brands currently available in the Indian market.Methods: Cost of oral anti-diabetic drugs manufactured by different pharmaceutical

APA, Harvard, Vancouver, ISO, and other styles

25

Karki, Naresh, Kamal Kandel, Kyushu Shah, Pravin Prasad, and Jeevan Khanal. "Combination Therapy in Diabetes Mellitus Patients Attending Outpatient Department in a Tertiary Care Centre: A Descriptive Cross-sectional Study." Journal of Nepal Medical Association 60, no. 256 (2022): 1016–20. http://dx.doi.org/10.31729/jnma.7642.

Full text

Abstract:

Introduction: Assessing anti-diabetic drug use patterns in hospitals is an important activity which helps to promote the rational use of drugs and may suggest measures to change prescribing habits for the better. This study aimed to find the use of combination therapy in diabetes mellitus patients attending the outpatient department of a tertiary care centre. Methods: A descriptive cross-sectional study was conducted among 201 diabetes mellitus patients in the internal medicine department from 2 March 2022 to 30 June 2022 for a duration of four months after approval from the Institutional Revi

APA, Harvard, Vancouver, ISO, and other styles

26

Verma, Suryakant, Milind Sharad Pande, Ravinder Kumar Mehra, et al. "Anti-diabetic Potential of Traditional Herbal Drugs in Polyherbal Formulation–A Review." Journal of Pharmaceutical Technology, Research and Management 12, no. 1 (2024): 33–51. https://doi.org/10.15415/jprtm.2024.121003.

Full text

Abstract:

Background: Diabetes mellitus, characterized by hyperglycemic symptoms, has emerged as a major global health challenge. The disease’s severity is compounded by both micro- and macrovascular complications associated with hyperglycemia, leading to significant morbidity. Current conventional anti-diabetic medications, while widely prescribed, often demonstrate high failure rates and are associated with adverse pathological effects. Purpose: This paper aims to evaluate the potential of polyherbal formulations in the treatment of diabetes mellitus, addressing the need for alternative therapeutic ap

APA, Harvard, Vancouver, ISO, and other styles

27

Verma, Suryakant, Milind Sharad Pande, Ravinder Kumar Mehra, et al. "Anti-diabetic Potential of Traditional Herbal Drugs in Polyherbal Formulation–A Review." Journal of Pharmaceutical Technology, Research and Management 12, no. 1 (2024): 33–51. https://doi.org/10.15415/jptrm.2024.121003.

Full text

Abstract:

Background: Diabetes mellitus, characterized by hyperglycemic symptoms, has emerged as a major global health challenge. The disease’s severity is compounded by both micro- and macrovascular complications associated with hyperglycemia, leading to significant morbidity. Current conventional anti-diabetic medications, while widely prescribed, often demonstrate high failure rates and are associated with adverse pathological effects. Purpose: This paper aims to evaluate the potential of polyherbal formulations in the treatment of diabetes mellitus, addressing the need for alternative therapeutic ap

APA, Harvard, Vancouver, ISO, and other styles

28

Wu, Ping, Zhenyu Liu, Xiaohong Jiang, and Hao Fang. "An Overview of Prospective Drugs for Type 1 and Type 2 Diabetes." Current Drug Targets 21, no. 5 (2020): 445–57. http://dx.doi.org/10.2174/1389450120666191031104653.

Full text

Abstract:

Aims: The aim of this study is to provide an overview of several emerging anti-diabetic molecules. Background: Diabetes is a complex metabolic disorder involving the dysregulation of glucose homeostasis at various levels. Insulin, which is produced by β-pancreatic cells, is a chief regulator of glucose metabolism, regulating its consumption within cells, which leads to energy generation or storage as glycogen. Abnormally low insulin secretion from β-cells, insulin insensitivity, and insulin tolerance lead to higher plasma glucose levels, resulting in metabolic complications. The last century h

APA, Harvard, Vancouver, ISO, and other styles

29

Hong, Jun Hwa. "Extent of Role: Anti-Diabetic Medications." Journal of Korean Diabetes 23, no. 3 (2022): 153–56. http://dx.doi.org/10.4093/jkd.2022.23.3.153.

Full text

Abstract:

In management of diabetes, glucose lowering is the basic target of treatment. Insulin is essential to type 1 diabetes. Non-insulin therapy in type 2 diabetes is very diverse and continuously developing to improve glucose control and prevent diabetes-related complications. In the recent 30 years, recommended specifications of anti-diabetic drugs are high glucose-lowering efficacy, low risk of hypoglycemia, less burden of weight gain, and cardiovascular safety. With development of SGLT2 inhibitors (sodium glucose cotransporter 2 inhibitors) and GLP-1RA (glucagon-like peptide-1 receptor agonist),

APA, Harvard, Vancouver, ISO, and other styles

30

Hemamalini, Saravanan K. L. Senthil Kumar. "Formulation And Evaluation Of Medicated Chewing Gum Containing Metformin And Glimepiride." International Journal of Pharmaceutical Sciences 2, no. 4 (2024): 503–20. https://doi.org/10.5281/zenodo.10943964.

Full text

Abstract:

The formulation and evaluation of MCG containing a combination of anti-diabetic drugs is a critical endeavor in pharmaceutical research, aiming to enhance drug efficacy and patient compliance in managing diabetes mellitus. Combining anti-diabetic drugs in a single formulation offers potential advantages such as synergistic effects, improved glycemic control and simplified dosing regimens. Micro-crystalline cellulose, a widely used pharmaceutical excipients, can serve as an ideal matrix for such formulations due to its inert nature, high surface area and excellent compressibility properties. Th

APA, Harvard, Vancouver, ISO, and other styles

31

Moumita, Hazra. "A Clinical Pharmacological Comparative Quantification Analytical Research Study Among Systematic Reviews and MetaAnalyses on Bronchodilators and Anti-Diabetic Drugs." International Journal of Toxicological and Pharmacological Research 12, no. 6 (2022): 50–57. https://doi.org/10.5281/zenodo.11656503.

Full text

Abstract:

<strong>Background: </strong>There are numerous systematic reviews and meta-analyses conducted on the β adrenergic agonistic bronchodilators, like salbutamol, formoterol, salmeterol and other β adrenergic agonists, as well as, on the anti-diabetic drugs, like biguanides, dipeptidyl peptidase-4 inhibitors and sodium glucose co-transporter-2 inhibitors. Systematic Review and Meta-Analysis, are the two very novel methods of Clinical Research Methods in Clinical Research, Pharmacology, Clinical Pharmacology, and Evidence-Based Medicine, integrated within Medical Sciences, that defin

APA, Harvard, Vancouver, ISO, and other styles

32

K., Lohit, Lakshmish Devang Halepalya Somashekar, Naveen Kumar, and Vidya K. R. "Anti-diabetic drugs prescription pattern by postgraduate students among type 2 diabetes patients attending a tertiary care hospital." International Journal of Basic & Clinical Pharmacology 8, no. 11 (2019): 2454. http://dx.doi.org/10.18203/2319-2003.ijbcp20194783.

Full text

Abstract:

Background: The pattern of prescribing anti-diabetic drugs varies among different medical professionals due to the availability of numerous anti-diabetic drugs and demographic and have increasingly favoured for tighter control of glycemic index. Even with the available multiple therapies many patients are not in control. The reasons may be multi factorial and the one important factor is the drugs prescribed.Methods: This cross-sectional study involving 140 type 2 adult diabetes patients was done to assess the pattern of anti-diabetic drugs prescribed by the postgraduate students in a tertiary

APA, Harvard, Vancouver, ISO, and other styles

33

Shadab, Usmani Humaira, Dr Mohd Muazzam Khan, ,. Dr Usama ahmad, et al. "Analysis of Prescribing Patterns and Adverse Drugs Reactions in Diabetic Patients at Tertiary Care Hospital, Lucknow." Indian Journal of Health Care, Medical & Pharmacy Practice 4, no. 1 (2023): 94–102. http://dx.doi.org/10.59551/ijhmp/2023.4.1.1010.

Full text

Abstract:

To study the prescribing pattern and adverse drug reactions (ADRs) of anti-diabetic drugs in a tertiary care hospital in Lucknow, India. Methods: A prospective study was conducted over a period of 6 months at the inpatient and outpatient departments of the hospital. A total of 100 patients with diabetes were included in our study. Demographic characteristics were recorded and 100 prescriptions were analyzed. ADRs were reported and analyzed. Results: Among the 100 patients, 58 were male and 42 were female. The majority of the patients were in the age group of 41-60 years. Biguanides (38%) and s

APA, Harvard, Vancouver, ISO, and other styles

34

Shadab, Usmani Humaira, Dr Mohd Muazzam Khan, Dr Usama Ahmad, et al. "Analysis of Prescribing Patterns and Adverse Drugs Reactions in Diabetic Patients at Tertiary Care Hospital, Lucknow." Indian Journal of Health Care, Medical & Pharmacy Practice 4, no. 1 (2023): 94–102. http://dx.doi.org/10.59551/ijhmp.25832069.2023.4.1.10.

Full text

Abstract:

To study the prescribing pattern and adverse drug reactions (ADRs) of anti-diabetic drugs in a tertiary care hospital in Lucknow, India. Methods: A prospective study was conducted over a period of 6 months at the inpatient and outpatient departments of the hospital. A total of 100 patients with diabetes were included in our study. Demographic characteristics were recorded and 100 prescriptions were analyzed. ADRs were reported and analyzed. Results: Among the 100 patients, 58 were male and 42 were female. The majority of the patients were in the age group of 41-60 years. Biguanides (38%) and s

APA, Harvard, Vancouver, ISO, and other styles

35

Shadab, Usmani Humaira, Dr Mohd Muazzam Khan, Dr Usama Ahmad, et al. "Analysis of Prescribing Patterns and Adverse Drugs Reactions in Diabetic Patients at Tertiary Care Hospital, Lucknow." INDIAN JOURNAL OF HEALTH CARE, MEDICAL AND PHARMACY PRACTICE 4, no. 1 (2023): 94–102. http://dx.doi.org/10.59551/ijhmp/2023.4.10.

Full text

Abstract:

To study the prescribing pattern and adverse drug reactions (ADRs) of anti-diabetic drugs in a tertiary care hospital in Lucknow, India. Methods: A prospective study was conducted over a period of 6 months at the inpatient and outpatient departments of the hospital. A total of 100 patients with diabetes were included in our study. Demographic characteristics were recorded and 100 prescriptions were analyzed. ADRs were reported and analyzed. Results: Among the 100 patients, 58 were male and 42 were female. The majority of the patients were in the age group of 41-60 years. Biguanides (38%) and s

APA, Harvard, Vancouver, ISO, and other styles

36

Singh, Dharmvir, Neetesh Kumar Jain, Apoorva Tiwari, and Neelam Khan. "Development and Validation of Simultaneous Equation Method for Estimation of Sitagliptin and Saxagliptin in Combined Pharmaceutical Dosage Form by Using UV Spectrophotometric Method." International Journal of Medical Sciences and Pharma Research 8, no. 2 (2022): 83–90. https://doi.org/10.22270/ijmspr.v8i2.43.

Full text

Abstract:

Day by day the number of drug groups also the numbers of drugs within these groups for treatment of diabetes are increasing rapidly. The numbers of newer anti-diabetic formulations either in single or in combined dosage forms are marketed and investigated, sitagliptin with saxagliptin are not official in any pharmacopoeia. the aim of the present work was to develop and validate newer analytical methods like UV spectrophotometric methods, which should be applied for the further analysis of anti-diabetic drugs in bulk drugs and its pharmaceutical formulations. To develop and validate simultaneou

APA, Harvard, Vancouver, ISO, and other styles

37

Tella, Toluwani, Carolina Pohl, and Kovalchuk Igor. "A review on diabetes mellitus: complications, synthetic anti-diabetic agents and herbal treatment." F1000Research 13 (February 19, 2024): 124. http://dx.doi.org/10.12688/f1000research.141015.1.

Full text

Abstract:

Background Diabetes mellitus is a metabolic disorder with multiple symptoms and complications. The management of these conditions involve the use of synthetic anti-diabetic agents, natural products and medicinal plants. Synthetic anti-diabetic agents are associated with side effects whereas medicinal plants have minimal side effects and are less expensive. The aim of this work is to highlight various (i) complications associated with diabetes (ii) synthetic anti-diabetic agents used for treatment (iii) medicinal plants as anti-diabetic agents. Methods Electronic databases such as Web of Scienc

APA, Harvard, Vancouver, ISO, and other styles

38

Adeghate, Ernest. "Medicinal Chemistry of Novel Anti-Diabetic Drugs." Open Medicinal Chemistry Journal 5, Suppl 2 (2011): 68–69. http://dx.doi.org/10.2174/1874104501105010068.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Oyama, Jun-ichi, and Koichi Node. "Vascular failure and recent anti-diabetic drugs." Vascular Failure 1, no. 1 (2017): 2–8. http://dx.doi.org/10.30548/vascfail.1.1_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Terauchi, Yasuo. "2. How to Select Anti-diabetic Drugs." Nihon Naika Gakkai Zasshi 110, no. 3 (2021): 556–61. http://dx.doi.org/10.2169/naika.110.556.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Dowarah, Jayanta, and Ved Prakash Singh. "Anti-diabetic drugs recent approaches and advancements." Bioorganic & Medicinal Chemistry 28, no. 5 (2020): 115263. http://dx.doi.org/10.1016/j.bmc.2019.115263.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Li, Zhu, Jia Jia, Han Hao, et al. "Anti-Diabetic Drugs Inhibit Bulimia Induced Obesity." Frontiers in Bioscience-Landmark 28, no. 5 (2023): 97. http://dx.doi.org/10.31083/j.fbl2805097.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Hulugappa, Lakshmi, Chethana Ramegowda, and Anwith Huluvadi Shivalingaiah. "Factors Influencing Oral Anti-diabetic Medication Adherence among Type 2 Diabetes Mellitus in Urban Health Training Centre, Bengaluru." National Journal of Community Medicine 13, no. 06 (2022): 386–90. http://dx.doi.org/10.55489/njcm.13062022405.

Full text

Abstract:

Background: Medication adherence is a major challenge in treatment of type 2 diabetes. Hence the present study was undertaken to assess the factors influencing drug adherence in Type 2 diabetes Bengaluru. Methods: A descriptive study was conducted in urban health training centre Bengaluru for a period of 9 months. A total of 70 type 2 Diabetes patients only on oral drugs willing to give informed consent were included. Institutional Ethical Committee clearance was obtained and pre-tested semi structured proforma was administered and the probable factors that affect adherence was included. Data

APA, Harvard, Vancouver, ISO, and other styles

44

Parmar, Mrugank, and Shital Panchal. "REPURPOSING DIABETES DRUGS FOR NEURODEGENERATIVE DISEASES: ANTI-DIABETIC DRUG REPOSITION." International Research Journal Of Pharmacy 9, no. 12 (2019): 81–87. http://dx.doi.org/10.7897/2230-8407.0912297.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Wu, Victor Chien-Chia, Yan-Rong Li, and Chao-Yung Wang. "Impact of Sodium–Glucose Co-Transporter 2 Inhibitors on Cardiac Protection." International Journal of Molecular Sciences 22, no. 13 (2021): 7170. http://dx.doi.org/10.3390/ijms22137170.

Full text

Abstract:

Sodium–glucose co-transporter 2 (SGLT2) inhibitors have been approved as a new class of anti-diabetic drugs for type 2 diabetes mellitus (T2DM). The SGLT2 inhibitors reduce glucose reabsorption through renal systems, thus improving glycemic control in all stages of diabetes mellitus, independent of insulin. This class of drugs has the advantages of no clinically relevant hypoglycemia and working in synergy when combined with currently available anti-diabetic drugs. While improving sugar level control in these patients, SGLT2 inhibitors also have the advantages of blood-pressure improvement and

APA, Harvard, Vancouver, ISO, and other styles

46

Chang, Wenguang, Li Chen, and Grant M. Hatch. "Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies." Biochemistry and Cell Biology 93, no. 5 (2015): 479–86. http://dx.doi.org/10.1139/bcb-2014-0107.

Full text

Abstract:

The incidence of type 2 diabetes is increasing rapidly worldwide, and the development of novel anti-diabetic drugs is emerging. However, most anti-diabetic drugs cannot be used in patients with hepatic dysfunction, renal disease, and heart disease, which makes pharmacological therapy of type 2 diabetes complicated. Despite continued introduction of novel agents, the search for an ideal drug that is useful as both a hypoglycemic agent and to reduce diabetes-related complications remains elusive. Berberine is an isoquinoline alkaloid extract that has shown promise as a hypoglycemic agent in the

APA, Harvard, Vancouver, ISO, and other styles

47

Pelin, Ana Maria, Cristian Catalin Gavat, Gabriela Balan, and Costinela Valerica Georgescu. "Pharmacological Principles Used in Patient Monitoring with Type 2 Diabetes." Revista de Chimie 68, no. 2 (2017): 378–83. http://dx.doi.org/10.37358/rc.17.2.5457.

Full text

Abstract:

This study assessed the medication used in type 2 diabetes treatment, depending on the glycaemia level and set out the oral anti-diabetics which are recommended, in three study stages: admission, hospitalization and discharge. Eighty patients were selected and diagnosed with diabetes mellitus 2 type, who were registered in the diabetes and nutrition diseases department within Sf. Apostol Andrei Galati Hospital. They were subjected to a series of laboratory tests: blood count, glycosylated haemoglobin, glycaemia level. It were established main classes of anti-diabetic drugs outpatient used and

APA, Harvard, Vancouver, ISO, and other styles

48

Rauniyar, G. P., R. Sinha, K. Chapagain, R. Maskey, and D. R. Pandey. "Effects of Momordica Charantia (Karela/bitterguord) in Type 2 Diabetic Patients Taking Allopathic Drugs: A pilot study." Kathmandu University Medical Journal 19, no. 2 (2021): 243–47. http://dx.doi.org/10.3126/kumj.v19i2.49655.

Full text

Abstract:

Background Momordica charantia is evolving as supplementary therapy in type 2 diabetes mellitus. Animal studies reveal its anti-diabetic and lipid lowering property. However, clinical studies with human subjects are very few. Objective To find out the effects of Momordica charantia supplements on glycemic and lipid profile among type 2 diabetes mellitus patients taking allopathic drugs. Method A comparative study was conducted in internal medicine department of B P Koirala Institute of Health Sciences, Dharan from July 2015 to May 2016 after ethical clearance. Twenty two uncomplica

APA, Harvard, Vancouver, ISO, and other styles

49

Kim, Kyung-Soo, and Byung-Wan Lee. "Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease." Clinical and Molecular Hepatology 26, no. 4 (2020): 430–43. http://dx.doi.org/10.3350/cmh.2020.0137.

Full text

Abstract:

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder and is associated with various metabolic diseases, including type 2 diabetes mellitus. There are no approved drugs for NAFLD, and the only approved treatment option is weight reduction. As insulin resistance plays an important role in the development of NAFLD, many anti-diabetic drugs have been evaluated for the treatment of NAFLD. Improvement of liver enzymes has been demonstrated by many anti-diabetic drugs, but histological assessment still remains insufficient. Pioglitazone could become the first-line therapy for T2

APA, Harvard, Vancouver, ISO, and other styles

50

SUVASHINI CHELLADURAI, MONIKA ARUMUGAM, ARUNKUMAR JEYARAJ, et al. "Study of cost variation analysis for oral anti-diabetic drugs dispensed in pharmacy." World Journal of Biology Pharmacy and Health Sciences 21, no. 2 (2025): 150–54. https://doi.org/10.30574/wjbphs.2025.21.2.0111.

Full text

Abstract:

The management of diabetes mellitus requires long-term pharmacological interventions, making the cost of anti-diabetic drugs a critical factor influencing treatment adherence and patient outcomes. In India, particularly in regions like Trichy, Tamil Nadu, significant cost variations in oral anti-diabetic drugs are observed across brands and formulations. In this study aims to analyze the price disparities and their potential implications on healthcare affordability and accessibility. In addition, we evaluate the cost variation among commonly prescribed oral anti-diabetic drugs, including Metfo

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!